Digital Best Practices for Accelerating Drug Development

Sponsored by: DocuSign
Speakers:

Ellen Reilly, VP, Life Sciences & Healthcare, DocuSign
Robert Albert, Collaboration Delivery Lead, AstraZeneca

Tuesday - November 10, 2015 / 1pm EST / 10am PT
Free Event

Nearly 90% of pharmaceutical executives agree that digital technologies are crucial to increasing efficiency and improving the customer experience. Investing in digital operations across your enterprise – from procurement contracts to 1572 forms – helps you launch products sooner and reduce development costs.

Learn about the impact of investing in fully digital operations and best practices for implementing a digital center of excellence across your enterprise. You’ll hear a firsthand account from a global pharmaceutical leader who has optimized their digital investment by engaging executive sponsors, setting core metrics, and developing an implementation roadmap.

Topics covered include:

  • Addressing industry challenges through digital investments
  • Top use cases for signing, sending and managing digital documents
  • How to drive adoption and change management
  • Lessons learned from building a digital center of excellence
  • Qualitative and quantitative impact
  • 21 CFR Part 11 compliance

About the Sponsors

DocuSign® helps more than 110,000 companies make their digital transformation to increase speed to results, reduce costs, enhance security and compliance, and delight clients with a secure digital experience. 14 of the top 15 global pharmaceutical companies and 9 of the top 10 CROs are DocuSign customers. For more information, visit www.docusign.com or call 877.720.2040.

For more information please visit www.docusign.com.

Comments are closed.

FEEDBACK